Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 3,486.236 million compared to CNY 2,782.174 million a year ago. Operating income was CNY 521.437 million compared to CNY 345.806 million a year ago. Net income was CNY 437.852 million compared to CNY 343.775 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.11 a year ago.